Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0658
D

Failure to Follow Insulin Pen Administration Protocol

Charlotte, North Carolina Survey Completed on 08-21-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency was identified when the Unit Coordinator failed to administer an insulin pen injection according to the facility's policy and professional standards. During a medication administration observation, the Unit Coordinator did not wait the required 6-10 seconds after fully depressing the insulin pen plunger before removing the needle from the resident's skin. Instead, the pen was removed immediately after the dose was delivered, which was observed to result in clear fluid draining from the injection site. The facility's policy specifically directs staff to keep the needle in the skin for up to 6-10 seconds after the dose is administered to ensure proper delivery of the medication. The resident involved had a diagnosis of type 2 diabetes and a physician's order for Novolog FlexPen insulin to be administered with meals. The Unit Coordinator, while preparing and administering the insulin, did not adhere to the required hold time after injection, and was unable to confirm how long the pen was held in place. Both the Unit Coordinator and the DON acknowledged that the policy was not followed during this administration, as the pen should not have been removed immediately after the dose was delivered.

An unhandled error has occurred. Reload 🗙